Evidence from in vitro, in vivo, and clinical studies showed that ADAM9 facilitates lung tumor cell proliferation, adhesion to vascular endothelial cells, anoikis resistance, cell migration, tumor angiogenesis, growth, and metastasis in xenograft models. Here, ADAM9 is linked to neoplasm.